Global Antifungal Therapeutics Market: Trends

and Opportunities (2014-2019)

View Report Details

Scope of the Report

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities

(2014- 2019)” provides an in-depth analysis of global antifungal therapeutics market with

focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It

provides broad coverage of these classes with detailed analysis of drugs and indications in

respective classes. It also assesses the key opportunities and underlying trends in the

market and outlines the factors that are and will be driving the growth of the industry in

the forecasted period (2014- 19). Further, key players of the industry such as Merck & Co.,

Inc., Pfizer Inc., Astellas Pharma Inc. and Noble Corporation SCYNEXIS, Inc. are also profiled

in the report.

Segment Coverage

Polyenes

Azoles

Echinocandin

s Allylamines

Company Coverage

Merck & Co.,

Inc. Pfizer Inc.

View Report Details

Astellas Pharma Inc.

SCYNEXIS Inc.

Executive Summary

Antifungal agents are drugs used for the treatment of fungal infections that can infect

almost any part of the body including skin, nails, respiratory tract, urogenital tract and

alimentary tract. Treatment of fungal infections currently available in the market can be

broadly classified into four major classes of antifungal drugs – Polyenes, Azoles, Allylamines

and Echinocandins. Global antifungal market is dominated by systemic antifungal infection.

Over the past several years, there have been high incidences of invasive fungal

infections around the globe. In response to this, various antifungal agents with novel action

mechanisms, broader action spectrum and fewer side effects have emerged. Growth within

global antifungal therapeutics market is driven by high number of cases of fungal infections,

rise in number of immune-compromised aged population and various government initiatives

in this field. Some of the restraints to market’s growth are growing resistance to antifungal

drugs, limitations with antifungal drugs, presence of generics and government regulations in

pharmaceutical industry. Major trends prevailing in the industry includes growth in

resistant strains and Candida & Aspergillus causing maximum fungal infections.

Global Antifungal Therapeutics Market: Overview

Antifungal agents are drugs used for treatment of fungal infections such as athlete’s

foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal

meningitis, and others ensuring minimal toxicity to the host.

Global Antifungal Therapeutics Market Size, 2011-13 (US$ Billions)

• Market size by global antifungal therapeutics market is expected to reach to US$ …….

Billions in the year 2019, from US$…………… billions in 2013 by growing at a CAGR of………

%.• Growth in the market is due to …………………………………………….

Global Antifungal Therapeutics Market Size Forecast, 2014E-19E (US$ Billions)

2011 2012

**Includes systemic antifungal data

20132014E 2015E 2016E 2017E 2018E 2019E

Global Antifungal Therapeutics Market ShareGlobal Antifungal Drug Class Market Share

by Value (2013)Global Antifungal Drug Type Market Share

by Value (2013)

Global Antifungal Drug Type Market Share by Volume (2013)

Global Antifungal Drug Class Market Share by Volume (2013)

Caspofungi n

aa%

Micafungin bb%

Amphotericin Bcc%

Voriconazole dd%

Posaconazo le

ee%

Fluconazole ff%

Azolesyy%

Echinocandi nszz%

Polyenes xx%

Caspofungin

h% Micafungin kk%

Amphoteric in B ll%

Voriconazol e

m%

Fluconazolenn%

Azoles ee%

Echinocandins

dd%

Polyenes cc%

1. Executive Summary

2. Antifungal Market

1. Fungal Infections

2.1.1 Fungal Infections: Types

2. Antifungal Treatment

3. Global Antifungal Therapeutics Market Analysis 4.3.3 Echinocandins Market Sizing (Actual &1. Global Antifungal Therapeutics Market Sizing

1.Global Antifungal Therapeutics Market Size

(Actual & Forecasted)

2. Global Antifungal Therapeutics Market Share

1. By Geography

2. By Organisms

3. Drug Class by Value

4. Drug Class by Volume

5. Drug Type by Value

6. Drug Type by Volume

4. Global Antifungal Therapeutics Market Segment 5.2 Challengesby Drug Type

1. Polyene Antifungal Drugs

1. Overview

2. Polyene Market Sizing (Actual & Forecasted)

4.2 Azoles Antifungal Drugs

1. Overview

2. Azoles Market Sizing (Actual & Forecasted)

3. Azoles Market Share by Drugs

4.3 Echinocandins Antifungal Drugs

4.3.1 Overview

Forecasted)

4.3.4 Echinocandins Market Share by Drugs

4.4 Allylamines

4.4.1 Overview

5. Global Antifungal Market Growth Drivers &

Challenges

1. Growth Drivers

1. High Incidences of Serious Fungal Infections

2. Ageing Population

3. Government Initiatives

1.Resistance to Antifungal Drugs

2. Government Regulation

3.Limitations Associated with Drugs Used for

Treatments

4. Presence of Generics

Table of Contents

Table of Contents

6. Global Antifungal Market Trends

1. Growth in Resistant Strains

2. Candida & Aspergillus Causing Maximum Fungal

Infections

7. Competitive Landscape

8. Company Profiles

1. Merck & Co., Inc.

1. Business Overview

2. Financial Overview

3. Business Strategies

2. Pfizer Inc.

1. Business Overview

2. Financial Overview

3. Business Strategies

3. Astellas Pharma Inc.

1. Business Overview

2. Financial Overview

3. Business Strategies

4. SCYNEXIS Inc.

1. Business Overview

2. Financial Overview

3. Business Strategies

List of ChartsFigure 1: Site of Action of the Common Antifungal Agents in Generalized Fungal Cell

Table 1: Competitive Profile of Antifungal Drug Classes

Figure 2: Global Antifungal Therapeutics Market Size by Value, 2011-13 (US$ Billions)

Figure 3: Global Antifungal Therapeutics Market Size by Value Forecasted, 2014E-19E (US$ Billions)

Figure 4: Global Antifungal Therapeutics Market Share by Region (2012E)

Figure 5: Global Antifungal Market by Organisms Causing Fungal Infection (2013)

Figure 6: Global Antifungal Drug Class Market Share by Value (2013)

Figure 7: Global Antifungal Drug Class Market Share by Volume (2013)

Figure 8: Global Antifungal Drug Type Market Share by Value (2013)

Figure 9: Global Antifungal Drug Type Market Share by Volume (2013)

Figure 10: Structure of Some Common Polyene Antifungal Agents

Table 2: Overview of Polyenes Market

Figure 11: Global Antifungal Class Polyene Market Size, 2011-13 (US$ Millions)

Figure 12: Global Antifungal Class Polyene Market Size Forecasted, 2014E-19E (US$ Millions)

Figure 13: Structure of Some Common Azoles Antifungal Agents

Table 3: Overview of Azoles Market

Figure 14: Global Antifungal Agent Azole Market Size by Drugs, 2011-13 (US$ Millions)

Figure 15: Global Antifungal Agent Azole Market Size Forecasted, 2014E-19E (US$ Millions)

Figure 16: Global Azoles Market Share by Drug Types (2013)

Figure 17: Structure of Some Common Echinocandins Antifungal Agents

Table 4: Overview of Echinocandins Market

Figure 18: Global Antifungal Agents Echinocandins Market Size by Drugs, 2011-13 (US$ Millions)

Figure 19: Global Antifungal Agents Echinocandins Market Size Forecasted, 2014E-19E (US$ Millions)

Figure 20: Global Echinocandins Market Share by Drug Types (2013)

Figure 21: Structure of Some Common Allylamines Antifungal Agents

Table 5: Incidence of Serious Fungal Infections

Table 6: Fungal Patients in the US and ROW

Figure 22: Global Aging Population, 2005-13E (Millions)

Figure 23: Growth in Candida glabrata Resistant Strains, 2001-10

Figure 24: Growth in Aspergillus fumigatus Resistant Strains, 2001-10

Table 7: Antifungal Drugs in Development for Systemic Candiasis and Aspergillosis

Table 8: Competitive Landscape for Antifungal Agents

Table 9: Antifungal Drug Sales by Indication

Table 10: Global Sales of Select Antifungal Drugs

Figure 25: Merck & Co., Inc. Revenue by Business Segment (2013)

Figure 26: Merck & Co., Inc. Antifungal Drugs (Cancidas & Noxafil) Revenue, 2010-13 (US$ Millions)

Figure 27: Pfizer Inc. Revenue by Business Segments (2013)

Figure 28: Pfizer Inc. Antifungal Drugs (Vfend & Diflucan) Revenue, 2011-13 (US$ Millions)

Figure 29: Astellas Pharma Inc. Sales by Geography (FY2013)

Figure 30: Astellas Pharma Inc. Antifungal Drugs (Funguard/Mycamine & AmBisome) Revenue, FY2010-FY2013

(US$ Millions)

Figure 31: SCYNEXIS, Inc. Revenue, FY2012-FY2013 (US$ Millions)

List of Charts

Daedal ResearchDaedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries.

For more details please contact Mr. Rajeev Kumar:

Tel: +91-120-4553017 (9.30 am - 6.30 pm) ISTMobile: +91-8743975789 (24 X7)Enquiries: info@daedal-research.com

Title: Global Antifungal Market: Trends and Opportunities (2014-2019)Published: August 2014Pages: 65Price: US$ 800 (Single-User License)

: US$ 1600 (Corporate License)

For placing an order of the Report, please press the following link:http://www.daedal-research.com/global-antifungal-therapeutics-markettrends-and-opportunities-2014-2019